HPRA Information Update
The Health Products Regulatory Authority has published the 103rd edition of its Drug Safety Newsletter. The special edition includes information about the EMA review of very rare cases of thrombosis in combination with thrombocytopenia following the Covid-19 vaccine Janssen.
For further details please visit the HPRA website.
|